Europe — EMA
Olmesartan Medoxomil E Amlodipina Mylan Italia (Olmesartan Medoxomil, Amlodipine)
Olmesartan medoxil, the active ingredient in Olmesartan Medoxomil E Amlodipina Mylan Italia, is an ARB presented as a oral tablet for systemic use. It treats hypertension in adult patients.
Request sourcing
What is Olmesartan Medoxomil, Amlodipine?
Olmesartan medoxil, the active ingredient in Olmesartan Medoxomil E Amlodipina Mylan Italia, is an ARB presented as a oral tablet for systemic use. It treats hypertension in adult patients. GNH USA supplies Olmesartan Medoxomil E Amlodipina Mylan Italia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Olmesartan Medoxomil E Amlodipina Mylan Italia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals pharmacies and clinics worldwide.
What is Olmesartan Medoxomil, Amlodipine used for?
Olmesartan medoxil/amlodipine combination therapy is used for managing cardiovascular conditions that involve high blood pressure.
- Hypertension: Improves blood pressure control when added to lifestyle changes. - Chronic kidney disease with hypertension: Helps slow the progression of kidney damage. - Heart failure with preserved ejection fraction: Supports symptom management and reduces hospitalisation risk. - Diabetes‑related vascular complications in hypertensive patients : Provides additional cardiovascular protection beyond blood‑pressure lowering. - Strat of cardiovascular risk in high risk patients : Offers added benefit when combined with other antihypertensives .
What are the side effects of Olmesartan Medoxomil, Amlodipine?
The … … … … … … ...
What precautions apply to Olmesartan Medoxomil, Amlodipine?
… … …
What does Olmesartan Medoxomil, Amlodipine interact with?
… ...
